Xu, Wei <br/><br/>
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.  [electronic resource] 

 -  International journal of biological sciences  2020 
 - 1388-1402 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1449-2288 
<br/><br/><label>Standard No.: </label>10.7150/ijbs.41627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Breast Neoplasms--genetics<br/>Cell Cycle<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cell Survival<br/>Checkpoint Kinase 1--biosynthesis<br/>Computational Biology<br/>Doxorubicin--pharmacology<br/>Drug Screening Assays, Antitumor--methods<br/>Estrogen Receptor alpha--biosynthesis<br/>Female<br/>Genome, Human<br/>Humans<br/>Kaplan-Meier Estimate<br/>MCF-7 Cells<br/>RNA Interference<br/>Receptors, Progesterone--biosynthesis<br/>Treatment Outcome